PROSPECTIVE RANDOMIZED 12-WEEK CONTROLLED STUDY OF VISUAL FIELD CHANGE IN SUBJECTS WITH PARTIAL SEIZURES RECEIVING PREGABALIN OR PLACEBO
PROSPECTIVE RANDOMIZED 12-WEEK CONTROLLED STUDY OF VISUAL FIELD CHANGE IN SUBJECTS WITH PARTIAL SEIZURES RECEIVING PREGABALIN OR PLACEBO
Patients with partial seizures currently taking 1-3 antiepileptic medications will have a 50:50 chance to receive Lyrica 300 mg per day or placebo (no active ingredients) added on to their current medications for 3 months. Neither the study doctor nor the patient will know the medication assignment. Vision testing will be performed prior to receiving the study treatment and at the end of the study to see if there are any changes.
Inclusion Criteria:
Exclusion Criteria:
Buffalo, New York 14209, United States
Mt. Pleasant, South Carolina 29464, United States
Milwaukee, Wisconsin 53226-3522, United States
Sofia, 1431, Bulgaria
Abids, Hyderabad, Andhra Pradesh 500 001, India
Secunderabad, Andhra Pradesh 500 003, India
Pune, Maharashtra 411004, India
Aquascalientes, Aquascalientes 20000, Mexico
Muang, Changwat Khon Kaen 40002, Thailand